nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of ototoxicity in a patient with metastatic carcinoma of the breast treated with paclitaxel and vinorelbine
|
Tibaldi, C. |
|
1998 |
34 |
7 |
p. 1133- 1 p. |
artikel |
2 |
Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues
|
Chan, J.Y.H |
|
1998 |
34 |
7 |
p. 1015-1022 8 p. |
artikel |
3 |
An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma
|
Michon, J.M |
|
1998 |
34 |
7 |
p. 1063-1069 7 p. |
artikel |
4 |
A novel method to culture laryngeal human papillomavirus-positive epithelial cells produces papilloma-type cytology on collagen rafts
|
Aaltonen, L.-M |
|
1998 |
34 |
7 |
p. 1111-1116 6 p. |
artikel |
5 |
A phase II study of DaunoXome® in advanced urothelial transitional cell carcinoma
|
Fosså, S.D. |
|
1998 |
34 |
7 |
p. 1131-1132 2 p. |
artikel |
6 |
A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer
|
Glück, S |
|
1998 |
34 |
7 |
p. 1008-1014 7 p. |
artikel |
7 |
Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1α (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010
|
Marshall, E |
|
1998 |
34 |
7 |
p. 1023-1029 7 p. |
artikel |
8 |
Correlation between plasma transforming growth factor-β1 and second primary breast cancer in a chemoprevention trial
|
Decensi, A |
|
1998 |
34 |
7 |
p. 999-1003 5 p. |
artikel |
9 |
Correspondence
|
|
|
1998 |
34 |
7 |
p. 1135-1136 2 p. |
artikel |
10 |
Correspondence
|
|
|
1998 |
34 |
7 |
p. 1134-1135 2 p. |
artikel |
11 |
Editorial
|
|
|
1998 |
34 |
7 |
p. 953-955 3 p. |
artikel |
12 |
Editorial
|
|
|
1998 |
34 |
7 |
p. 964-965 2 p. |
artikel |
13 |
Editorial
|
|
|
1998 |
34 |
7 |
p. 956-957 2 p. |
artikel |
14 |
Effect of anthraquinone-laxatives on the proliferation and urokinase secretion of normal, premalignant and malignant colonic epithelial cells
|
Schörkhuber, M |
|
1998 |
34 |
7 |
p. 1091-1098 8 p. |
artikel |
15 |
Entry into clinical trials in breast cancer: the importance of specialist teams
|
Twelves, C.J. |
|
1998 |
34 |
7 |
p. 1004-1007 4 p. |
artikel |
16 |
Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: preparation of a genetically engineered anti-CEA single chain Fv antibody
|
Mayer, A |
|
1998 |
34 |
7 |
p. 968-976 9 p. |
artikel |
17 |
Five days of oral topotecan (hycamtin®), a phase I and pharmacological study in adult patients with solid tumours
|
Gerrits, C.J.H |
|
1998 |
34 |
7 |
p. 1030-1035 6 p. |
artikel |
18 |
Flow cytometric analyses of the specific activation of peripheral blood mononuclear cells from healthy donors after in vitro stimulation with a fermented mistletoe extract and mistletoe lectins
|
Stein, G.M |
|
1998 |
34 |
7 |
p. 1105-1110 6 p. |
artikel |
19 |
Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO)
|
Rau, B |
|
1998 |
34 |
7 |
p. 992-998 7 p. |
artikel |
20 |
Inhibition of growth of primary human tumour cell cultures by a 4-anilinoquinazoline inhibitor of the epidermal growth factor receptor family of tyrosine kinases
|
Baguley, B.C |
|
1998 |
34 |
7 |
p. 1086-1090 5 p. |
artikel |
21 |
Intratumoral microvessel density and expression of ED-A/ED-B sequences of fibronectin in breast carcinoma
|
D’Ovidio, M.C |
|
1998 |
34 |
7 |
p. 1081-1085 5 p. |
artikel |
22 |
No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer
|
Givehchian, M |
|
1998 |
34 |
7 |
p. 1099-1104 6 p. |
artikel |
23 |
[No title]
|
Kingston, J.E. |
|
1998 |
34 |
7 |
p. 1048-1049 2 p. |
artikel |
24 |
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)
|
Monnet, I |
|
1998 |
34 |
7 |
p. 1124-1127 4 p. |
artikel |
25 |
Production of trypsins by human gastric cancer cells correlates with their malignant phenotype
|
Kato, Y |
|
1998 |
34 |
7 |
p. 1117-1123 7 p. |
artikel |
26 |
Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial
|
Helsing, M |
|
1998 |
34 |
7 |
p. 1036-1044 9 p. |
artikel |
27 |
Retinoblastoma
|
Zucker, J.M |
|
1998 |
34 |
7 |
p. 1045-1048 4 p. |
artikel |
28 |
Should patients with advanced carcinomas be treated with chemotherapy?
|
Rouëssé, Contra: J |
|
1998 |
34 |
7 |
p. 962-964 3 p. |
artikel |
29 |
Should patients with advanced sarcomas be treated with chemotherapy?
|
Benjamin, Pro: R.S. |
|
1998 |
34 |
7 |
p. 958-962 5 p. |
artikel |
30 |
Single agent infusional 5-fluorouracil is not effective second-line therapy after raltitrexed (Tomudex®) in advanced colorectal cancer
|
Farrugia, D.C |
|
1998 |
34 |
7 |
p. 987-991 5 p. |
artikel |
31 |
The BRCA paradox in breast and ovarian cancer
|
Ponzone, R |
|
1998 |
34 |
7 |
p. 966-967 2 p. |
artikel |
32 |
The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women
|
Talamini, R |
|
1998 |
34 |
7 |
p. 1070-1076 7 p. |
artikel |
33 |
The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature
|
Hejna, M |
|
1998 |
34 |
7 |
p. 977-986 10 p. |
artikel |
34 |
Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen
|
Raderer, M |
|
1998 |
34 |
7 |
p. 1128-1130 3 p. |
artikel |
35 |
Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84
|
Flamant, F |
|
1998 |
34 |
7 |
p. 1050-1062 13 p. |
artikel |
36 |
Truncated TSG101 transcripts are present in peripheral blood from both familial breast cancer patients and controls
|
Xu, C.-F. |
|
1998 |
34 |
7 |
p. 1077-1080 4 p. |
artikel |